TNM staging is obsolete

Journal of Surgical Oncology

Volumn 95, Issue 1, 2007, Pages 8-9

  Hodul, Pamela J ^a   Yeatman, Timothy J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SIZE; CANCER STAGING; COMPARATIVE GENOMIC HYBRIDIZATION; EDITORIAL; GENE EXPRESSION PROFILING; HUMAN; METASTASIS POTENTIAL; MOLECULAR EPIDEMIOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 33846305385     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20634     Document Type: Editorial

References (7)

1. Fleming ID, Cooper JS, Henson DE, et al.: AJCC Cancer Staging Manual. Philadelphia: Lippincott-Raven, 1997.
2. Gdeedo A, Van Schil P, Corthouts B, et al.: Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 1997;12:224-227.
3. Kehoe J, Khatri VP: Staging and prognosis of colon cancer. Surg Oncol Clin N Am 2006;15:129-146.
4. Roskell DE, Buley ID: Traditional and established indicators of prognosis and treatment success. Methods Mol Med 2006;120:79-89.
5. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-572.
6. Eschrich S, Yang I, Bloom G, et al.: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005;23:3526-3535.
7. Paik S, Shak S, Tang G, et al.: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-2826.